UPDATE: Sterne Agee Upgrades M.D.C. Holdings on Current Valuation
In a report published Thursday, Sterne Agee analyst Jay McCanless upgraded M.D.C. Holdings (NYSE: MDC) from Neutral to Buy and maintained a $36 price target.
In the report, Sterne Agee stated, "We believe investors have overlooked the potential for easy operating comparisons in FY14, and at current levels, we view the stock as undervalued."
M.D.C. Holdings closed on Wednesday at $29.01.
Latest Ratings for MDC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | JP Morgan | Maintains | Neutral | |
| Nov 2021 | Raymond James | Maintains | Strong Buy | |
| Oct 2021 | JP Morgan | Downgrades | Overweight | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Jay McCanless Sterne AgeeAnalyst Color Upgrades Analyst Ratings
